Our EUPATI Annual General Meeting (AGM) took place on 24th–25th September 2026 in Belgium, bringing together EUPATI Fellows, National Platform representatives, Sustaining Partners, regulators and HTA actors from across Europe and beyond.
The event focused on the role of learning and education in patient involvement in health innovation, and concluded with EUPATI’s position on “Data & Dialogue”: how training can strengthen patient involvement through the systematic use of patient experience data (PED).
Thank you to everyone who joined us, and to our sponsors, partners, speakers, moderators, session organisers and secretariat team for making it so memorable! Thank you to our onsite photographer Arshia Foroughi, for capturing the energy and connections.
Keep an eye on our social media platforms over the next few months as we continue to share about the programme.
Interested in joining our partnership? Find out more here.
AGM 2026 Position Statement
Patient Experience Data in Medicines R&D — From Recognition to Action through Education
Patient experience data (PED) is emerging as a vital source of evidence in the development of new medicines and health technologies. This statement sets out EUPATI’s position on the role of training and education in enhancing patient involvement through PED, as defined by the EUPATI Sustaining Partners, Fellows and National Platforms.
You can access our AGM 2026 position statement here.
Our Values
who we are, how we work and what we stand for
-
Reliable
-
Inclusive
-
Collaborative
-
Impactful
-
Innovative
Our Community
